GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SciSparc Ltd (NAS:SPRC) » Definitions » ROE % Adjusted to Book Value

SPRC (SciSparc) ROE % Adjusted to Book Value : -231.05% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SciSparc ROE % Adjusted to Book Value?

SciSparc's ROE % for the quarter that ended in Jun. 2024 was -94.73%. SciSparc's PB Ratio for the quarter that ended in Jun. 2024 was 0.41. SciSparc's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -231.05%.


SciSparc ROE % Adjusted to Book Value Historical Data

The historical data trend for SciSparc's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciSparc ROE % Adjusted to Book Value Chart

SciSparc Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -51.04 -44.97 -161.87

SciSparc Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -83.10 169.04 -110.35 -170.18 -231.05

Competitive Comparison of SciSparc's ROE % Adjusted to Book Value

For the Biotechnology subindustry, SciSparc's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciSparc's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SciSparc's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SciSparc's ROE % Adjusted to Book Value falls into.



SciSparc ROE % Adjusted to Book Value Calculation

SciSparc's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-72.84% / 0.45
=-161.87%

SciSparc's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-94.73% / 0.41
=-231.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciSparc ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SciSparc's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


SciSparc Business Description

Industry
Traded in Other Exchanges
N/A
Address
20 Raul Wallenberg Street, Tower A, 2nd Floor, Tel Aviv, ISR, 6971916
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

SciSparc Headlines